The Effect of High-dose Vitamin C Treatment for Acute Respiratory Failure due to Coronavirus Disease Pneumonia on Mortality and Length of Intensive Care Stay: A Retrospective Cohort Study
Nurcan Coskun, Hacer Musta Altinay, Sebnem Turk, Nebia Peker, Serkan Islamoglu, Surhan Ayse, Melis Turkel Cinar, Ozkan, Etfal Sisli, Hospital, Sebnem Hacer, MD. Sisli Hamidiye Turk, Egitim Etfal, Arastirma Ve, Saglik Bilimleri Hastanesi, Universitesi, Türkiye İstanbul
SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital, doi:10.14744/semb.2022.66742
S evere acute respiratory syndrome coronavirus 2 (SARS- CoV-2) causes tissue damage in the endothelium and epithelium, increasing vascular permeability and the risk of lung edema. The expressions of interleukin (IL) 6, IL-2, IL-7, IL-10, interferon gamma, and tumor necrosis factor α are thought to induce an interstitial fibrosis in the lung by causing an abnormal increase (cytokine storm) in plasma levels. [1] [2] [3] When these pathogenic factors are taken into account, a table with high mortality from acute respiratory failure and severe acute respiratory distress syndrome (ARDS) emerges in patients with coronavirus disease (CO-VID-19) followed up in the intensive care unit (ICU). The low Objectives: In our study, we aimed to determine the effect of vitamin C on short-term mortality and length of intensive care unit (ICU) stay in patients with coronavirus disease (COVID-19) followed up in the ICU. Methods: The patients who received and those who did not receive the high-dose intravenous vitamin C protocol were assigned to the treatment and control groups, respectively. The primary study findings in both groups were length of ICU stay and shortterm mortality, while the secondary findings were vasopressor and invasive mechanical ventilation requirements and change in sequential organ failure assessment score from the 0 to the 96th hour. Results: Thirty-eight patients were included in the treatment group and 40 were included in the control group. The mortality rates were 44% and 60% in the treatment and control groups, respectively; however, the difference between the groups was not statistically significant (p>0.05). The median length of ICU stay in both groups was 10 days (p>0.05). No significant differences in the invasive mechanical ventilation and vasopressor requirements were found between the groups (p>0.05). Conclusion: Consequently, the high-dose vitamin C therapy in the patients with acute respiratory failure due to COVID-19 pneumonia did not reduce the length of ICU stay, mortality, and invasive mechanical ventilation and vasopressor reqirements.
References
Alhazzani, Møller, Arabi, Loeb, Gong, Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19), Intensive Care Med,
doi:10.1007/s00134-020-06022-5Beigmohammadi, Bitarafan, Hoseindokht, Abdollahi, Amoozadeh et al., Impact of vitamins A, B, C, D, and E supplementation on improvement and mortality rate in ICU patients with coronavirus-19: a structured summary of a study protocol for a randomized controlled trial, Trials,
doi:10.1186/s13063-020-04547-0Carcillo, Sward, Halstead, Telford, Jimenez-Bacardi et al., National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network Investigators. A Systemic inflammation mortality risk assessment contingency table for severe sepsis, Pediatr Crit Care Med,
doi:10.1097/PCC.0000000000001029Carsana, Sonzogni, Nasr, Rossi, Pellegrinelli et al., Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study, Lancet Infect Dis,
doi:10.1016/S1473-3099(20)30434-5Cheng, Li, Li, Liu, Yan et al., Ferritin in the coronavirus disease 2019 (COVID-19): a systematic review and metaanalysis, J Clin Lab Anal,
doi:10.1002/jcla.23618Chiscano-Camón, Ruiz-Rodriguez, Ruiz-Sanmartin, Roca, Ferrer, Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome, Crit Care,
doi:10.1186/s13054-020-03249-yDohlen, Jones, Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure. The CITRIS-ALI randomized clinical trial, J Emerg Med,
doi:10.1016/j.jemermed.2020.01.026Fowler Aa 3rd, Syed, Knowlson, Sculthorpe, Farthing et al., Medical Respiratory Intensive Care Unit Nursing. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis, J Transl Med,
doi:10.1186/1479-5876-12-32Fowler Aa 3rd, Truwit, Hite, Morris, Dewilde et al., Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial, Erratum in,
doi:10.1001/jama.2019.11825Hernández, Papadakos, Torres, González, Vives et al., Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19, Rev Esp Anestesiol Reanim (Engl Ed),
doi:10.1016/j.redar.2020.03.004Hwang, Park, Jo, Kim, Chung et al., Society (KoSS) Investigators. Combination therapy of vitamin C and thiamine for septic shock in a multicentre, doubleblind, randomized, controlled study (ATESS): study protocol for a randomized controlled trial, Trials,
doi:10.1186/s13063-019-3542-xKim, Jo, Eom, Mok, Kim et al., Combined vitamin C, hydrocortisone, and thiamine therapy for patients with severe pneumonia who were admitted to the intensive care unit: propensity score-based analysis of a before-after cohort study, J Crit Care,
doi:10.1016/j.jcrc.2018.07.004Kim, Kim, Na, Shin, A study of intravenous administration of vitamin C in the treatment of acute herpetic pain and postherpetic neuralgia, Ann Dermatol,
doi:10.5021/ad.2016.28.6.677Marik, Khangoora, Rivera, Hooper, Catravas, Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study, Chest,
doi:10.1016/j.chest.2016.11.036Moskowitz, Huang, Hou, Gong, Doshi et al., Trial Investigators. Effect of ascorbic acid, corticosteroids, and thiamine on organ injury in septic shock: the ACTS randomized clinical trial, JAMA,
doi:10.1001/jama.2020.11946Mrityunjaya, Pavithra, Neelam, Janhavi, Halami et al., Immune-boosting, antioxidant and anti-inflammatory food supplements targeting pathogenesis of COVID-19, Front Immunol,
doi:10.3389/fimmu.2020.570122Quartuccio, Semerano, Benucci, Boissier, Vita, Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome, Joint Bone Spine,
doi:10.1016/j.jbspin.2020.03.011Sağlık, Bakanlığı, COVID-19 (SARS-CoV-2 Enfeksiyonu) Rehberi
Vincent, Moreno, Takala, Willatts, Mendonça et al., The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine, Intensive Care Med,
doi:10.1007/BF01709751Wilson, Wynn, Pulmonary fibrosis: pathogenesis, etiology and regulation, Mucosal Immunol
Zabet, Mohammadi, Ramezani, Khalili, Effect of highdose Ascorbic acid on vasopressor's requirement in septic shock, J Res Pharm Pract,
doi:10.4103/2279-042X.179569DOI record:
{
"DOI": "10.14744/semb.2022.66742",
"ISSN": [
"1302-7123"
],
"URL": "http://dx.doi.org/10.14744/SEMB.2022.66742",
"author": [
{
"affiliation": [],
"family": "Coskun",
"given": "Nurcan",
"sequence": "first"
}
],
"container-title": "SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital",
"container-title-short": "Sisli Etfal",
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2022,
12,
13
]
],
"date-time": "2022-12-13T07:33:52Z",
"timestamp": 1670916832000
},
"deposited": {
"date-parts": [
[
2022,
12,
13
]
],
"date-time": "2022-12-13T07:33:57Z",
"timestamp": 1670916837000
},
"indexed": {
"date-parts": [
[
2022,
12,
14
]
],
"date-time": "2022-12-14T06:19:13Z",
"timestamp": 1670998753119
},
"is-referenced-by-count": 0,
"issued": {
"date-parts": [
[
2022
]
]
},
"member": "5966",
"original-title": [],
"prefix": "10.14744",
"published": {
"date-parts": [
[
2022
]
]
},
"published-online": {
"date-parts": [
[
2022
]
]
},
"published-print": {
"date-parts": [
[
2022
]
]
},
"publisher": "Kare Publishing",
"reference-count": 0,
"references-count": 0,
"relation": {},
"resource": {
"primary": {
"URL": "https://sislietfaltip.org/jvi.aspx?un=SETB-66742&volume="
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [
"General Medicine"
],
"subtitle": [],
"title": "The Effect of High-dose Vitamin C Treatment for Acute Respiratory Failure due to Coronavirus Disease Pneumonia on Mortality and Length of Intensive Care Stay: A Retrospective Cohort Study",
"type": "journal-article"
}
